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Abstract
Background: Diabetes mellitus is a chronic disease that causes short and long-term complications. This study aimed 
to investigate the prevalence of sexual dysfunctions (SD) among diabetic patients in Iran and to examine whether 
glycemic control has a role in SD.
Methods: A consecutive sample of diabetic women and men who were registered in the Isfahan Endocrine and 
Metabolism Center, Iran were studied. Sexual dysfunction was evaluated using the Female Sexual Function Index (FSFI) 
in women and the International Index of Erectile Function (IIEF) in men. In addition the level of glycosylated 
hemoglobin was assessed to classify the diabetes status in patients.
Results: In all 200 patients (100 male and 100 female) were entered into the study. The mean age of patients was 48.6 
(SD = 7.3) years and most had type 2 diabetes (91.0%). The results showed that sexual dysfunctions were widespread in 
both gender and 165 (82.5%) patients reported that experienced at least one sexual dysfunction. There were significant 
associations between sexual dysfunctions and gender and type of diabetes (P = 0.04). Women and patients with type 1 
diabetes had higher rates of SD. No major differences were found between SD and age, diabetes status, duration of 
diabetes and hypertension. In addition, glycemic control did not show a significant association with SD in both 
genders.
Conclusion: The findings of this study showed that SD prevalence was high in diabetic patients of both genders and 
the glycemic control did not correlate with the frequency of SD in the study population. It is recommended that SD 
should be addressed more precisely in health care practice in Iran.
Background
Diabetes currently affects 246 million people in world
and is expected to affect 380 million by 2025. In addition
by 2025 the largest increases in diabetes prevalence will
take place in developing countries [1]. Hyperglycemia in
diabetic patients can cause short and long term complica-
tions. The long-term problems occur 5-10 years after
diagnosis in both types of diabetes and could be pre-
vented or postponed by precise controlling of blood sugar
(BS) level. The amount of BS can be monitored daily
either by patient or clinician while in long-term method
glycosylated hemoglobin (GH) is checked [2]. GH is a
blood test that reflects average blood glucose levels over a
period of approximately two to three months after its
raise. The longer the amount of glucose in the blood, the
more binding of glucose to hemoglobin is expected [2].
Therefore the range of GH is an objective measurement
for controlling diabetes in patients with the disease.
There are more supplementary recommended standards
of medical care in patients with diabetes: measurement of
blood pressure at every routine diabetes visits, annual
measurement of fasting lipid profile, screening for risk
factors of: coronary heart disease, neuropathy, retinopa-
thy, nephropathy and foot care. In addition, it has been
advised that people with diabetes should receive individ-
ualized medical nutrition therapy and the usage of fat and
carbohydrate must be limited [3].
Diabetes' complications can affect nervous system
including a group of ailments that involve peripheral,
autonomous and spinal cord nerves. Autonomic nervous
system imperfections accounts for a vast range of these
disorders that would engage all body systems including
cardiovascular, gastrointestinal, urinary, adrenalin glands
and reproductive system [2]. Their prevalence is associ-
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ated with age, weight, disease duration, GH level, choles-
terol level, hypertension and smoking. In all diabetes
could affect patients' life in several ways. For instance
since patients with diabetes should receive individualized
medical nutrition thus one might expect that patients
change their regular nutrition habits. In addition the
stigma associated with a chronic disease such as diabetes
might have effect on patients' social life and perhaps
cause social isolation. It is well recognized that social iso-
lation is an important risk factor for depression [4].
Sexual dysfunction (SD) as a diabetes-related difficulty
is common among both male and female patients [5,6].
Despite over 70 years of research, sexuality of females
with diabetes mellitus remains a controversial issue.
Despite over 70 years of research sexuality of females
with diabetes mellitus remains a controversial issue.
There is a debate that type of diabetes has an impact on
the emergence of SD in women with diabetes. Research
indicates that women with type 1 diabetes are mostly
affected by SD compared to type 2 diabetics and healthy
women [7]. Overall studies suggest women with diabetes
report more sexual dysfunctions compared to their coun-
terparts and increased diabetes related complications can
intensify the SD problems in patients [8]. Sexual prob-
lems in women with diabetes mostly include sexual
desire, sexual satisfaction, orgasmic disorder, arousal dis-
order and lubrication [9,10]. It seems that somatic sen-
sory system is affected by diabetes and intruitos vagina,
labium minora and clitoris are the most deteriorated gen-
ital sites in diabetic women. Even though manifesting of
sexual difficulties is not always expected and medication
can improve blood flow in clitoris [11,12]. It is argued
that neuropathy, vascular impairment, and psychological
complaints are recognized factors in the pathogenesis of
female sexual dysfunction in diabetic women [13]. In
addition endocrine changes may cause diminished vagi-
nal lubrication in women who suffer from diabetes; how-
ever it has rarely been documented as a sexual problem in
female sufferers [14]. In men with diabetes erectile dys-
function is more frequent than other men of the same age
[15]. Diabetes causes damage to nerves throughout the
body including penis and erectile dysfunction generates
as common diabetes' complication [16]. A number of
men with autonomic neuropathy can experience normal
erectile function and orgasm but do not ejaculate nor-
mally that could be verified through urine analysis [2].
Research indicates although erectile dysfunction is wide-
spread among men with diabetes; the condition is often
remains undiagnosed and demands appropriate assess-
ment and initiation of proper treatment [17]. A study by
Zdravko supported the hypothesis that in the complex
pathogenesis of diabetic erectile dysfunction (ED), dia-
betic neuropathy is the major pathogenic factor [18].
Other research findings are indicative that the etiology of
ED is a multifactor disorder and in the management of
diabetic ED, a holistic approach should be applied [19].
This study aimed to assess the differences between con-
trolled and uncontrolled diabetic cases of both gender in
Isfahan, Iran.
Methods
Participants and data collection
A cross-sectional study was conducted among 200 dia-
betic patients of both genders who were registered in
Isfahan Endocrine and Metabolism Center. The sample
was selected in a consecutive procedure from November
2002 to May 2003. The sample size was estimated on the
basis of a single proportion design. We assumed that at
best 50% of the patients would have controlled diabetes
status. Thus, a study with a sample of 206 diabetic
patients would have 80% power to detect a difference of
5% (45-55%) at the 0.05 significance level. The sample
size actually obtained for this study was 200 (100 men
and 100 women with diabetes).
The subjects were categorized into two groups: female
and male and based on their level of GH were set into
controlled (GH less than 10%) and uncontrolled (GH
more than or equal to 10%) clusters [20]. The subjects
were matched with regard to their age, type and duration
of diabetes. The inclusion criteria were identified as: reg-
istered for a year or longer (these patients had received all
their two to three recent HbA1c tests in a year that let the
researcher to use the mean of GH test in the study), his-
tory of diabetes for ten years or longer [21], existing of at
least two GH analyses in their case records, being mar-
ried and aged 30 and over (Most of the registered patients
in Isfahan Endocrine and Metabolism Center are with
type 2 diabetes and the disease is most prevalent among
35 years and over. Therefore the age range ≥30 was
defined as inclusion criteria).
Exclusion criteria included: record of mastectomy, total
hysterectomy, prostate and pelvic surgeries, benign pros-
tate hypertrophy (BPH), prostate cancer, Peyronie's dis-
ease, pregnancy, polygamy, patients who by himself or
their spouses were rising up in single parent families [22],
existence of sexual disorders in patients' spouse, anemia
and presence of sexual disorders before getting diabetes.
However, we did not control the presence of depressive
symptoms and type of medication.
Measures
1 .  S e x u a l  d y s f u n c t i o n :  s e x u a l  d y s f u n c t i o n s  w e r e  m e a -
sured in women and men using standard questionnaires.
The Female Sexual Function Index (FSFI) is a known
instrument that assesses sexual function in women with
six domains [23]: desire, arousal, lubrication, orgasm, sat-
isfaction and pain during sexual intercourse. The shorter
form (5 items) of the International Index of Erectile Func-Ziaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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tion (IIEF) [24] was used to measure SD in men. It evalu-
a t e s  s e x u a l  f u n c t i o n  i n  f i v e  a r e a s :  e r e c t i l e  f u n c t i o n ,
orgasmic function, sexual desire, intercourse satisfaction
and overall satisfaction. Due to cultural issues we did not
ask about 'intercourse satisfaction' from male patients.
Each item is rated on a 5-point scale. For the purpose of
analysis, relative to responses patients were divided into
two groups: with sexual problems, and without SD. In
women, the FSFI score <17 and in men the IIEF score <14
were the criteria for accepting the presence of sexual dys-
function.
2. Clinical measures: we used available data from Isfa-
han Metabolism and Endocrine Centre where all patients
received routine clinical examination that included
recording of: duration of diabetes, type of diabetes, body
mass index (BMI), fasting blood sugar, previous GH tests,
blood pressure, cholesterol and triglycerides levels and
diabetes-related complications. The micro-vascular com-
plications included recording of retinopathy, nephropa-
thy, and neuropathy (peripheral, autonomic), whereas
macro-vascular complications included recording of ath-
erosclerosis, heart disease and stroke. All hypertensive
cases were being treated with antihypertensive regimes.
In addition, morning urine analysis was carried out in
men as a test for evaluating retrograde ejaculation disor-
der [2]. It was expected that lots of active sperms would
be found in the morning urine in men with the disorder.
3. Demographic data: this included recording of
patients' age, occupation and socio-economic status.
Socioeconomic position was estimated using three indi-
cators: income, home ownership and family size. Patients
were categorized into two groups: those with good condi-
tions (good) and those with intermediate or poor condi-
tions (less than good).
Statistical analysis
Data were analysed using SPSS 15 in a descriptive and
analytical fashion. To investigate the associations of
demographic and clinical characteristics of the patients
with SD the χ2 test was used.
Ethical considerations
The ethics committee of Isfahan Endocrine and Metabo-
lism Center approved the study. All patients were entered
into the study after an informed verbal consent. Diabetic
women and men were informed by female and male
interviewers separately and were assured regarding the
confidentiality of the information.
Results
In all 200 cases (100 men and 100 women) were studied.
The mean age of patients was 48.6 (SD = 7.3). The mean
age of men was 50.9 while it was 46.3 for women. Most
patients had type 2 diabetes (91.0%). Demographic and
clinical characteristics of the study sample are shown in
Table 1.
Table 2 presents the relationship between SD and
demographic and clinical characteristics of the study
sample. The results showed that there was a significant
association between presence of SD and gender (P = 0.04)
w her e  wom e n w e r e  m or e  a ff ect ed by S D c om pa r ed t o
men (88 versus 77%). Higher age groups experienced ele-
vated rate of SD, although there was no significant differ-
ence among different age groups (P = 0.13). Uncontrolled
cases and patients with hypertension reported higher
incidence of SD. In addition diabetes duration did not
show a significant association with experience of SD.
However all patients with diabetes type 1 had SD and a
significant association was found between SD and type of
diabetes (P = 0.04).
The frequency of SD items in men with diabetes for
each group are shown in Table 3. Men in controlled and
uncontrolled groups did not show significant differences.
However, except for erectile function where the fre-
quency was the same between both groups, in other SD
items cases with uncontrolled diabetes had higher dys-
functions.
Table 4 shows the frequency of SD in women with dia-
betes for each group. The findings signified that uncon-
trolled patients showed higher dysfunctions in all items
except for satisfaction disorders. Furthermore no signifi-
cant associations were found in SD between controlled
and uncontrolled female patients.
Discussion
This study examined SD using standard measures among
200 diabetic women and men. Most cases (91.0%) had
diabetes type 2 and findings indicated that patients in
both genders were greatly affected by SD problems. How-
ever the incidence of SD among women was higher than
men. A study on diabetic female and male cases found
that the prevalence of sexual dysfunction in diabetic men
approached 50% whereas in diabetic women it was
slightly lower [13]. Overall high rate of SD in patients
with diabetes are reported in different studies. A study
from Iran showed that diabetes significantly impairs the
sexual performance of women with diabetes [25]. A study
by Doruk demonstrated that female sexual dysfunctions
involved women with diabetes in all SD items and the rate
of involvement were higher among type 1 diabetic cases
[7]. Further research in the U.S has indicated that women
with type 2 diabetes may experience similar sexual func-
tioning to women without the disease; while women with
type 1 diabetes may report more SD including dyspare-
unia [26]. Studies on men with diabetes also have indi-
c a t e d  h i g h  o c c u r r e n c e  o f  S D  i n  t h e  p a t i e n t s .  S e l v i n
reported that the prevalence of erectile dysfunction was
over 50% in men with diabetes in the U.S [27]. A studyZiaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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Table 1: Demographic and clinical characteristics of study sample (n = 200)
Total (n = 200) Men (n = 100) Women (n = 100)
No (%) No (%) No (%)
Age group (years)
30-39 27(100.0) 12(44.5) 15(55.5)
40-49 84(100.0) 28(33.3) 56(66.7)
50-59 89(100.0) 60(67.4) 29(32.6)
Mean (SD) 48.6(7.3) 50.9(8.3) 46.3(5.2)
Occupation
Employed 107(100.0) 100(93.4) 7(6.6)
Housewife 93(100.0) 0.00 93(100.0)
Economic status
Good 41(100.0) 20(48.8) 21(51.2)
Less than good 159(100.0) 80(50.3) 79(49.7)
Duration of diabetes (years)
10-14 160(100.0) 75(46.8) 85(53.2)
15-19 31(100.0) 21(67.7) 10(32.3)
20-25 9(100.0) 4(44.4) 5(55.6)
Type of diabetes
Type1 18(100.0) 9(50.0) 9(50.0)
Type2 182(100.0) 91(50.0) 91(50.0)
Diabetes status
Controlled 100(100.0) 50(50.0) 50(50.0)
Uncontrolled 100(100.0) 50(50.0) 50(50.0)
Hypertension
Yes 21(100.0) 13(61.9) 8(38.1)
No 179(100.0) 87(48.6) 92(51.4)
Triglyceride
≤200 127(100.0) 76(59.8) 51(40.2)
201≥ 73(100.0) 24(32.9) 49(67.1)
Cholesterol
≤200 53(100.0) 35(66.0) 18(44.0)
201≥ 147(100.0) 65(44.2) 82(55.8)
FBS
60-130 63(100.0) 34(53.9) 29(46.1)
131≥ 137(100.0) 66(48.2) 71(51.8)
BMI
≤20 123(100.0) 50(40.6) 73(59.4)
21-25 58(100.0) 31(53.4) 27(46.6)
26≥ 19(100.0) 12(63.1) 7(36.9)Ziaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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from the Netherlands stated that the prevalence of erec-
tile dysfunction in patients with type 2 diabetes was
about 41.3% [28]. Studies from Saudi diabetic patients
reported moderate to severe erectile dysfunction among
80 to 90% of the patients [29,30]. However, the prevalence
of erectile dysfunction among diabetic men varies
between 35-90% [19]. In addition, in this study retrograde
ejaculation was reported in 15 diabetic male cases that
indicate a normal ejaculation. In general, compared to
most previous research this study found a higher preva-
lence of SD among men and women with diabetes (88% of
women and 77% of men). There is a limited data regard-
ing SD prevalence in patients with diabetes of both gen-
ders in Iran. The high prevalence could be explained by
the fact that we did not control for psychological factors
affecting SD in diabetes. Moreover this study investigated
a small and heterogeneous sample. Further research
should focus on all influential factors that might relate to
prevalence of SD in diabetic patients in Iran.
In this study we did not find any significant statistical
relationship between age and SD. However higher age
groups experienced elevated rates of SD (Table 2). Other
research has reported age as a prognostic factor on preva-
lence of SD among patients with diabetes. El-Sakka in his
study reported that 32% of diabetic male patients less
than 50 years had erectile dysfunction compared to 67.6%
incidence in patients over 50 years [31]. The effect of
increased age on prevalence of SD in patients with diabe-
tes of both genders are well documented [25,32-34].
Moreover, no statistical associations were found
between clinical characteristics of patients including dia-
betes status, duration of diabetes and hypertension with
SD. Similarly a study from Turkey indicated that no risk
factor predicted SD in diabetic women [7]. Enzlin from
Belgium has reported also that SD in type 1 diabetic
women did not correlate with age, BMI, duration of dia-
betes, glycemic control, using medication, menopausal
status or complications [8]. Nonetheless, it has been sug-
gested that a normal glycemic control in type 2 diabetic
women would be fundamental to restoring normal sexual
activity in diabetic women [5]. Besides, in men with dia-
betes there have been significant associations between
control of diabetes mellitus and normal total testosterone
levels at 3 and 6 months follow-up visits [35]. Studies
Table 2: Sexual dysfunction (SD) by gender, age, diabetes status, duration of diabetes, type of diabetes and hypertension
With SD (n = 165) Without SD (n = 35) P
No (%) No (%)
Gender (n = 200) 0.04
Women (n = 100) 88 (88.0) 12 (12.0)
Men (n = 100) 77 (77.0) 23 (23.0)
Age groups (years) 0.13
30-39 15(68.2) 7(31.8)
40-49 74(82.2) 16(17.8)
50-59 76(86.4) 12(13.6)
Diabetes status 0.35
Controlled 80(80.0) 20(20.0)
Uncontrolled 85(85.0) 15(15.0)
Duration of diabetes (years) 0.64
10-14 130(81.2) 30(18.8)
15-19 27(87.1) 4(12.9)
20-25 8(88.8) 1(11.2)
Hypertension 0.31
Yes 19(90.5) 2(9.5)
No 146(81.6) 33(18.4)
Type of diabetes 0.04*
Type 1 18 (100.0) 0.00
Type 2 147(80.8) 35(19.2)
*Fisher's exact testZiaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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have shown that poor glycemic control, longer duration
of diabetes, and chronic diabetic complications such as
hypertension are related to elevated incidence of SD in
female and male diabetic cases [25,30,35-38].
The findings of this study showed that type of diabetes
had a significant effect on SD and all the type 1 diabetic
cases presented with SD (Table 2). This is similar to find-
ings by other researchers indicating a higher incidence of
SD among type 1 diabetic patients [7,26,39].
Considering the high prevalence of SD among patients
with diabetes, it seems the management of these disor-
ders should be acknowledged more precisely in health
care setting. It is argued that in the absence of definitive
treatment evidence, psychological counseling along with
hormonal therapies may relieve the SD in female patients
with diabetes [40,41]. In general patients with diabetes
may benefit from educational interventions to reduce the
SD impact on their personal life [42]. In addition, cogni-
tive behavior therapy, problem solving skills and improv-
ing family communications might help to minimize the
outcomes of SD among the patients. Indeed effective
interactions with diabetic patients who suffer from sexual
problems remain as the main task of health care work-
force.
This study provided useful data on SD using standard
instruments in a group of patients with diabetes of both
genders. As discussed in this study no major differences
were found between SD and age, diabetes status, duration
of diabetes and hypertension. In addition, glycemic con-
trol did not show a significant association with SD in both
genders. Such observations might be explained by the
fact that the small sample size and heterogeneity of the
sample did not allow to detect statistical significance
between SD and age, diabetes status, duration of diabetes
and hypertension. Furthermore evaluating SD among
male cases was somehow restricted where one item
(intercourse satisfaction) was not included in the ques-
tionnaire. Defining GH level less than 10% in the study
Table 3: Frequency of Sexual Dysfunction (SD) scales in men with diabetes
Total (n = 100) Controlled 
(n = 50)
Uncontrolled 
(n = 50)
OR* (95% CI**) P (χ2)
No (%) No (%) No (%)
Erectile 
dysfunction
1.00 (0.28-3.53) 1.00 (0.00)
Yes 14(100.0) 7(50.0) 7(50.0)
No 86(100.0) 43(50.0) 43(50.0)
Orgasmic 
dysfunction
0.78 (0.16-3.66) 0.72 (0.12)
Yes 9(100.0) 4(44.4) 5(55.6)
No 91(100.0) 46(50.5) 45(49.5)
Sexual desire 0.56 (0.33-1.35) 0.15 (2.03)
Yes 59(100.0) 26(44.0) 33(56.0)
No 41(100.0) 24(58.5) 17(41.5)
Overall 
satisfaction
0.49 (0.20-1.23) 0.09 (2.78)
Yes 64(100.0) 28(43.7) 36(56.3)
No 36(100.0) 22(61.1) 14(38.9)
Retrograde 
ejaculation
0.62 (0.18-2.13) 0.40 (0.71)
Yes 15(100.0) 6(40.0) 9(60.0)
No 85(100.0) 44(51.8) 41(48.2)
Decreased 
seminal fluid
0.62 (0.18-2.13) 0.40 (0.71)
Yes 15(100.0) 6(40.0) 9(60.0)
No 85(100.0) 44(51.8) 41(48.2)
*Odds ratio
**Confidence intervalZiaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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sample also would be considered as another explanation
that did not reveal significant association between SD
and diabetes status. In addition we did not control for the
presence of depressive symptoms and some risk factors
(such as smoking) for developing SD in diabetic patients.
Moreover this study assessed patients with type 1 and 2
diabetes of both genders. As most patients in this study
were detected with type 2 diabetes, we could not find any
significant associations between SD and demographic
and clinical variables. However all patients with type 1
diabetes presented with SD and it was found that there is
a significant association between type of diabetes and SD.
Perhaps future studies should include all risk factors so
that one gets more precise findings. Finally, to have a bet-
ter insight into the association between SD and variables
studied, a multivariate analysis is recommended in order
to exclude the effects of covariates on the association of
variables. Therefore future studies on the topic should
overcome these limitations and planning prospective
studies would be of great importance and worthiness.
Above all one should be aware that in this study sexual
dysfunctions in females were not diagnosed according to
the DSM-IV and AFUD diagnostic criteria, using a non-
standard cut-off score in the FSFI scale (where the stan-
dard cut-off score should be less than 26.55) and not
studying the presence of distress in the subjects. In some
instances the scores in the FSFI do not correlate with the
true presence of SD. In fact using different instruments
for assessing sexual dysfunctions can produce different
estimates [43].
Conclusion
The findings of this study showed that SD prevalence was
high in diabetic patients of both genders and the glycemic
control did not correlate with the frequency of SD in the
study population. It is recommended that SD should be
addressed more precisely in health care practice in Iran.
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Table 4: Frequency of Sexual Dysfunction (SD) scales in women with diabetes
Total (n = 100) Controlled 
(n = 50)
Uncontrolled 
(n = 50)
OR* (95% CI**) P (χ2)
No (%) No (%) No (%)
Desire disorders 0.84 (0.34-2.08) 0.67 (0.18)
Yes 66(100.0) 32(48.5) 34(51.5)
No 34(100.0) 18(52.9) 16(47.1)
Arousal 
disorders
0.47 (0.09-2.29) 0.29 (1.10)
Yes 9(100.0) 3(33.3) 6(66.7)
No 91(100.0) 47(51.6) 44(48.4)
Lubrication 
disorders
0.81 (0.30-2.18) 0.64 (0.21)
Yes 26(100.0) 12(46.2) 14(53.8)
No 74(100.0) 38(51.3) 36(48.7)
Orgasmic 
disorders
0.26 (0.03-1.46) 0.08 (3.05)
Yes 9(100.0) 2(22.3) 7(77.7)
No 91(100.0) 48(52.7) 43(47.3)
Satisfaction 
disorders
1.61 (0.47-5.00) 0.40 (0.71)
Yes 85(100.0) 44(51.8) 41(48.2)
No 15(100.0) 6(40.0) 9(60.0)
Pain disorders 0.52 (0.20-1.33) 0.13 (2.29)
Yes 31(100.0) 12(38.7) 19(61.3)
No 69(100.0) 38(55.1) 31(44.9)
*Odds ratio
**Confidence intervalZiaei-Rad et al. Reproductive Biology and Endocrinology 2010, 8:50
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